- 透過 PBPs-1b 和 PBPs-2 結合抑制細胞壁合成
- 與 Cilastatin, a renal dehydropeptidase-l inhibitor 同時使用以保護 [[Imipenem]] 
	- Primaxin$^\textregistered$
	- 25% serum protein bound
- 注射後穿透進多數組織，除了 cerebrospinal fluid，隨後隨尿液排出
- 用於治療嚴重感染
	- aerobic gram-negative bacilli,
	- anaerobes
	- S. aureus
- 副作用
	- irritation at the infusion site
	- nausea
	- vomiting
	- diarrhea
	- pruritus 瘙癢症
	- induce seizures
		- impaired renal function
		- preexisting CNS disease 
		- infection
		- use of large doses
![[Pasted image 20230426133556.png]]
![[Pasted image 20230426133625.png]]